学术交流

关于举行荷兰格罗宁根大学Alexander Domling教授 学术报告会的通知


报告题目:Automation and miniaturization of synthetic chemistry is leading to acceleration of drug discovery

报 告 人:Alexander Domling教授(荷兰格罗宁根大学)

主 持 人:王均 教授

报告时间:2019624日(星期一)10:00

报告地点:大学城校区B12-318会议室

欢迎广大师生参加!

  

生物医学科学与工程学院

2019619

附件:

报告人简介:Domling is an internationally recognized chemist borne in Munchen/Germany 08.10.1964. He studied chemistry & biology at the Technical University Munchen (Germany) and performed his PhD under the supervision of Ivar Ugi. Then he went to perform his postdoctoral studies in the laboratories of Nobel Laureate Barry Sharpless at Scripps (California). He then performed his Habilitation at the Technical University Munchen (Germany) and went to become associate professor at the University of Pittsburgh for 8 years. There he was promoted to become full professor. Most recently he became professor and chair of the department of drug design at the University of Groningen (Netherlands). He holds secondary appointments at PITT and Jagiellonian University (Krakow, Poland). His research in the areas of multidisciplinary, organic and medicinal chemistry, biochemistry, pharmacology, oncology and biophysics is published in more than 250 journal articles, reviews and book chapters (with a recent average of 20 publications per year). His h-index is 41 and the number of citations exceeds 14.000. He strives to bridge academic research outcomes to the market and has formed several biotech companies, incl. Morphochem, Carmolex and most recently SMIO.